AstraZeneca's COVID-19 vaccine sales beats estimate; 2021 outlook raised to reflect Alexion acquisition

AstraZeneca's COVID-19 vaccine sales beats estimate; 2021 outlook raised to reflect Alexion acquisition

SeekingAlpha

Published